Written for administrators and managers, direct service providers, health and social service professionals, educators, policymakers and planners in all settings serving older adults and their families. Each issue offers diverse perspectives on a single topic related to aging, providing in-depth coverage of practice, policy, research and theory. Generations DOES NOT accept bylined articles/submissions for the print publication but the AgeBlog DOES accept them. Follow the link for additional guidelines and information: http://asaging.org/sites/default/files/files/AgeBlog_Author_Guidelines_06-2013.pdf

Provided for public policy experts, professionals, and practitioners involved in the study of aging and its effects on individuals. Contains news and features covering public policy, research, practice issues and related topics concerning the needs and wants of aging. Offers research, practice and policy perspectives on frequently underrepresented and underserved segments of the older population. Committed to advancing a new standard of professionalism in aging, with diversity and cultural competence at its core.

Background and Format: Generics Bulletin is a comprehensive source of accurate, up-to-the-minute, global generic medicines news and analysis. It has subscribers in all of the world’s leading generic pharmaceutical companies. Deals of all kinds are the lifeblood of the generics industry, and are therefore the focus of Generics Bulletin. Indeed, many deals have been initiated by an item that first appeared in the editorial or advertising columns of Generics Bulletin. Dossiers, ingredients, products or even companies have been advertised in Generics Bulletin, as have contract research, manufacturing and consultancy services; conferences and meetings; and situations vacant. It also provides a platform for ‘Appointments’ advertising for senior generics sector vacancies. The magazine is read by generic medicines industry executives worldwide. These include: genetics manufacturers and producers, researchers and producers of APIs, generics formulators, generics litigation specialists, generics marketers, generics distributors, generics industry suppliers, generics regulators. Advertising information can be found at www.generics-bulletin.com/advertise.aspx. Circulation: Source: Publisher.

Generocity is a site dedicated to offering news that focuses on social issues Philadelphia, PA, and the nonprofits and mission groups that use their resources to have an impact on those issues.

Publishes research papers of broad general interest and biological significance in the areas of molecular biology, molecular genetics, and related fields. Uses two research formats; research papers and short research communications, in addition to review articles and perspectives. Topics include molecular genetics, human disease, cancer research, neurobiology, developmental and plant biology. Covers aspects of the life sciences and provides answers to the most actively investigated questions. Media Kit: http://genesdev.cshlp.org/site/misc/2012_Media_Kit.pdf

Dedicated to functional genetics of the immune response. Emphasizes studies which demonstrate genetic, genomic or functional variation in the immune system, and assists in the understanding of how the basic control over the immune system varies between individuals both in health and disease.

Geneseo Republic is a weekly newspaper providing news and information for Geneseo, IL. The advertising deadline is noon CT on Wednesdays.

Geneseo Republic is a weekly newspaper providing news and information for Geneseo, IL.

Established in 1981 and written for biotech and biopharma professionals involved in research, technical and commercial management. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues, new products and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups and literature information and articles relating to research projects and the production of biotechnology products.Regular topics in the publication include drug discovery technologies and R&D, trends in instrumentation, genomics and downstream omics, gene therapy, industrial biotechnology, enzymes, bioprocessing strategies, contract manufacture, monoclonal antibodies, bioinformatics, cell culture, LIMS, business issues and regulatory issues.Features the channels: Biobusiness which covers financial, business or patent related; Drug Discovery handles technical issues related to early stages of research and finding new pharmaceuticals; Omics spotlights genomics, proteomics and technologies such as metabolomics and Translational Medicine focuses on clinical and scientific efforts that concerns research and clinical settings. Other sections: Podcasts; Blogs; New Products; Best of the Web; GEN Updates RNAi; Oligonucleotides; Next-Generation Sequencing; Jobs; Classified Mart Marketplace; Real Estate; Conferences/Meetings; and Biotech Companies.The site offers RSS (Really Simple Syndication) and a digital Podcast.The publication DOES accept article submissions. Articles should be submitted to Managing Editor. Articles can be submitted either as POV articles, tutorials, overviews for the Transitional Medicine section, or online. For POV articles, they should be submitted one to two months in advance and should be about 1000 words. For tutorials, the articles should be submitted 4-6 months in advance and should be 1000-12000 words. For the Transitional Medicine section, these articles should be overviews, as opposed to specific points of view. They should also be 1000 words. For the online perspectives, they should be submitted a week before.

Intended for scientists and engineers working in bioproduct research, development and bioprocess. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups, new products and literature information, and articles relating to research projects and the production of biotechnology products.